Compare VITL & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VITL | CDNA |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 944.3M | 1.0B |
| IPO Year | 2020 | 2007 |
| Metric | VITL | CDNA |
|---|---|---|
| Price | $20.02 | $18.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $42.56 | $27.33 |
| AVG Volume (30 Days) | ★ 2.1M | 655.1K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.03 | N/A |
| EPS | ★ 1.44 | N/A |
| Revenue | ★ $759,444,000.00 | $48,324,000.00 |
| Revenue This Year | $26.07 | $15.37 |
| Revenue Next Year | $20.95 | $11.23 |
| P/E Ratio | $13.90 | ★ N/A |
| Revenue Growth | ★ 25.26 | 18.93 |
| 52 Week Low | $19.75 | $10.96 |
| 52 Week High | $53.13 | $21.49 |
| Indicator | VITL | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 23.17 | 45.09 |
| Support Level | N/A | $18.30 |
| Resistance Level | $31.02 | $20.94 |
| Average True Range (ATR) | 1.24 | 0.86 |
| MACD | -0.58 | -0.05 |
| Stochastic Oscillator | 3.04 | 52.31 |
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.